AKT1 and B-cell chronic lymphocytic leukemia: In a new experimental TCL1 mouse model of CLL with a constitutively active Akt allele (Akt-C) in B cells, the development of an aggressive lymphoma and a massive splenomegaly was reported by the age of 7 months confirming the driving role of AKT for RT-like transformations.